These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6416232)

  • 1. Valproate-ethosuximide combination therapy for refractory absence seizures.
    Rowan AJ; Meijer JW; de Beer-Pawlikowski N; van der Geest P; Meinardi H
    Arch Neurol; 1983 Dec; 40(13):797-802. PubMed ID: 6416232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid and ethosuximide interaction.
    Mattson RH; Cramer JA
    Ann Neurol; 1980 Jun; 7(6):583-4. PubMed ID: 6776874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of lamotrigine in the treatment of absence epilepsy crises].
    Mauri-Llerda JA; Tejero-Juste C; Iñiguez C; Morales-Asín F
    Rev Neurol; 2001 Feb 1-15; 32(3):247-50. PubMed ID: 11310280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ethosuximide and valproate in the treatment of epilepsy.
    Wallace SJ
    Neurol Clin; 1986 Aug; 4(3):601-16. PubMed ID: 3092003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence seizures: valproate or ethosuximide?
    Santavuori P
    Acta Neurol Scand Suppl; 1983; 97():41-8. PubMed ID: 6424396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of treatment in typical absence seizures. The roles of long-term EEG monitoring and ethosuximide.
    Blomquist HK; Zetterlund B
    Acta Paediatr Scand; 1985 May; 74(3):409-15. PubMed ID: 3923777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How long to treat childhood onset absence epilepsy.
    Amit R; Vitale S; Maytal J
    Clin Electroencephalogr; 1995 Jul; 26(3):163-5. PubMed ID: 7554303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Absence seizures in adulthood: four cases].
    Ribacoba Montero R; Salas Puig J; Ferreiro Martín D
    Neurologia; 1994 Jan; 9(1):25-8. PubMed ID: 8161464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiepileptic drugs on absence-like seizures in the tremor rat.
    Hanaya R; Sasa M; Ujihara H; Fujita Y; Amano T; Matsubayashi H; Serikawa T; Uozumi T
    Epilepsia; 1995 Sep; 36(9):938-42. PubMed ID: 7649134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.
    Posner EB; Mohamed K; Marson AG
    Seizure; 2005 Mar; 14(2):117-22. PubMed ID: 15694565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of valproate and ethosuximide: antiepileptic and neurotoxic interaction.
    Bourgeois BF
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1128-32. PubMed ID: 3144596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detailed monitoring of valproic acid and phenobarbital in the treatment of epilepsy in children].
    Sobaniec W; Jankowicz E; Czerwińska-Ciechan K
    Neurol Neurochir Pol; 1988; 22(5):413-20. PubMed ID: 3150521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal).
    Callaghan N; O'Hare J; O'Driscoll D; O'Neill B; Daly M
    Dev Med Child Neurol; 1982 Dec; 24(6):830-6. PubMed ID: 6818076
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy.
    Penovich PE; Willmore LJ
    Epilepsia; 2009 Sep; 50 Suppl 8():37-41. PubMed ID: 19702732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethosuximide and valproate display high efficacy against lindane-induced seizures in mice.
    Kaminski RM; Tochman AM; Dekundy A; Turski WA; Czuczwar SJ
    Toxicol Lett; 2004 Dec; 154(1-2):55-60. PubMed ID: 15475178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of "antiabsence" activity of sodium valproate by THIP in rats with petit mal-like seizures. Comparison with ethosuximide.
    Vergnes M; Marescaux C; Micheletti G; Rumbach L; Warter JM
    J Neural Transm; 1985; 63(2):133-41. PubMed ID: 3930659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy?
    Schmitt B; Kovacevic-Preradovic T; Critelli H; Molinari L
    Neuropediatrics; 2007 Apr; 38(2):83-7. PubMed ID: 17712736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epilepsy with myoclonic absences].
    Salas Puig J; Acebes A; González C; Tuñón A; Guisasola LM; Lahoz CH
    Neurologia; 1990; 5(7):242-5. PubMed ID: 2126943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
    N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.